BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease (COPD) (BEAM COPD)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01551953 |
Recruitment Status
:
Completed
First Posted
: March 13, 2012
Last Update Posted
: February 27, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Chronic Obstructive Pulmonary Disease (COPD) | Behavioral: Tai chi Behavioral: Mind-body breathing Behavioral: Education | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 124 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Other |
Official Title: | BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease |
Study Start Date : | February 2011 |
Actual Primary Completion Date : | April 2016 |
Actual Study Completion Date : | April 2016 |
Arm | Intervention/treatment |
---|---|
Experimental: tai chi exercise |
Behavioral: Tai chi
12 week tai chi class
|
Experimental: mind-body breathing |
Behavioral: Mind-body breathing
12 week breathing class
|
Active Comparator: education |
Behavioral: Education
12 week education class
|
- Feasibility of tai chi intervention [ Time Frame: 12 weeks ]Willingness to participate, adherence, and safety
- Change from baseline- Disease specific quality of life [ Time Frame: baseline, 12 weeks, 24 weeks ]Chronic Respiratory Questionnaire
- Change from baseline- Exercise capacity [ Time Frame: baseline, 12 weeks, 24 weeks ]six-minute walk distance, cardiopulmonary exercise testing
- Change from baseline- Dyspnea [ Time Frame: baseline, 12 weeks, 24 weeks ]UCSD Shortness of Breath Questionnaire
- Change from baseline- Psychosocial well-being [ Time Frame: baseline, 12 weeks, 24 weeks ]CES-D, Perceive Stress Scale, COPD Self-Efficacy Scale, Multidimensional Scale of Percieved Social Support
- Change from baseline- Pulmonary function [ Time Frame: baseline, 12 weeks, 24 weeks ]Spirometry and lung volumes
- Change from baseline- Physical strength and flexibility [ Time Frame: baseline, 12 weeks, 24 weeks ]Chair Sit and Reach, Chair Stand

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Moderate-severe COPD
- Age ≥ 40 years
Exclusion Criteria:
- Subjects with respiratory failure or GOLD stage 4 who are unable to safely perform a 6 minute walk test or otherwise safely exercise as deemed by a physician.
- COPD exacerbation requiring steroids, antibiotics, ED visit or hospitalization within the past 2 weeks unless physician deems subject at baseline
- Planned major pulmonary intervention within the next 3 months
- Hypoxemia on walk test or cardiopulmonary exercise test
- Inability to ambulate due to vascular or other neuromuscular conditions that would preclude a walk test
- Clinical signs of unstable cardiovascular disease
- Severe cognitive dysfunction
- Non-English speaking
- Current active participation in pulmonary rehabilitation program or current regular practice of tai chi
- Physician diagnosis of unstable/untreated clinical depression
- History of lung cancer

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01551953
United States, Massachusetts | |
VA Healthcare System | |
Boston, Massachusetts, United States, 02130 | |
Beth Israel Deaconess Medical Center | |
Boston, Massachusetts, United States, 02215 |
Principal Investigator: | Gloria Yeh, MD, MPH | BIDMC, Harvard Medical School |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Gloria Y. Yeh, Associate Professor of Medicine, Beth Israel Deaconess Medical Center |
ClinicalTrials.gov Identifier: | NCT01551953 History of Changes |
Other Study ID Numbers: |
2010P000412 R01AT005436 ( U.S. NIH Grant/Contract ) |
First Posted: | March 13, 2012 Key Record Dates |
Last Update Posted: | February 27, 2017 |
Last Verified: | February 2017 |
Keywords provided by Gloria Y. Yeh, Beth Israel Deaconess Medical Center:
chronic bronchitis emphysema pulmonary COPD |
Additional relevant MeSH terms:
Lung Diseases Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases |